EVOK - Evoke Pharma Inc
IEX Last Trade
4.22
-0.090 -2.133%
Share volume: 19,956
Last Updated: Fri 30 Aug 2024 02:17:22 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$4.31
-0.09
-2.09%
Fundamental analysis
42%
Profitability
50%
Dept financing
14%
Liquidity
50%
Performance
40%
Performance
5 Days
-2.72%
1 Month
-14.47%
3 Months
-17.05%
6 Months
-42.34%
1 Year
-70.33%
2 Year
-87.41%
Key data
Stock price
$4.22
DAY RANGE
N/A - N/A
52 WEEK RANGE
$3.75 - $18.60
52 WEEK CHANGE
-$0.71
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/07/2024
Company detail
CEO: David Gonyer
Region: US
Website: https://evokepharma.com/
Employees: 23
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: https://evokepharma.com/
Employees: 23
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
evoke pharma is a biotechnology company located in 505 lomas santa fe dr, solana beach, california, united states.
Recent news